Get the Stockscreener App
6.85
2.70%
-0.19
After Hours:
6.85
Lyra Therapeutics Inc stock is traded at $6.85, with a volume of 13,439.
It is down -2.70% in the last 24 hours and up +1.48% over the past month.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
See More
Previous Close:
$7.04
Open:
$7.01
24h Volume:
13,439
Relative Volume:
0.07
Market Cap:
$11.26M
Revenue:
$1.47M
Net Income/Loss:
$-97.61M
P/E Ratio:
-4.5973
EPS:
-1.49
Net Cash Flow:
$-80.90M
1W Performance:
-2.14%
1M Performance:
+1.48%
6M Performance:
-26.50%
1Y Performance:
-51.95%
1-Day Range:
$6.71
$7.15
1-Week Range:
$6.71
$7.50
52-Week Range:
$3.8101
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Name
Lyra Therapeutics Inc
Sector
Industry
Phone
617-373-4600
Address
480 ARSENAL WAY, WATERTOWN, MA
Compare LYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
6.85 | 11.58M | 1.47M | -97.61M | -80.90M | -1.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Downgrade | BofA Securities | Buy → Underperform |
| May-07-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-07-24 | Downgrade | Jefferies | Buy → Hold |
| May-06-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-06-23 | Resumed | BTIG Research | Buy |
| Aug-31-23 | Initiated | H.C. Wainwright | Buy |
| May-24-22 | Initiated | Cantor Fitzgerald | Overweight |
| May-26-20 | Initiated | BTIG Research | Buy |
| May-26-20 | Initiated | BofA/Merrill | Buy |
| May-26-20 | Initiated | Jefferies | Buy |
| May-26-20 | Initiated | William Blair | Outperform |
View All
Lyra Therapeutics Inc Stock (LYRA) Latest News
What Fibonacci levels say about Lyra Therapeutics Inc. reboundGap Down & Free AI Powered Buy and Sell Recommendations - Newser
Should you wait for a breakout in Lyra Therapeutics Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Full technical analysis of Lyra Therapeutics Inc. stock2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - Newser
Why is Neuphoria Therapeutics Inc. stock going upPortfolio Update Summary & Expert Approved Trade Ideas - خودرو بانک
Lyra Therapeutics Inc. Stock Flags Risk Zone in Volatility Index2025 Top Gainers & Growth Focused Stock Reports - beatles.ru
Is Lyra Therapeutics Inc. stock bottoming outDividend Hike & Smart Money Movement Alerts - Newser
Tick level data insight on Lyra Therapeutics Inc. volatilityJuly 2025 Highlights & Consistent Growth Equity Picks - Newser
What MACD signals say about Lyra Therapeutics IncJuly 2025 Summary & Real-Time Volume Triggers - Newser
Can Lyra Therapeutics Inc. lead its sector in growthQuarterly Risk Review & Risk Controlled Stock Pick Alerts - خودرو بانک
Key metrics from Lyra Therapeutics Inc.’s quarterly dataPortfolio Update Summary & Free Weekly Watchlist of Top Performers - Newser
How to build a dashboard for Lyra Therapeutics Inc. stock2025 Risk Factors & Technical Buy Zone Confirmations - Newser
Building trade automation scripts for Lyra Therapeutics Inc.Watch List & Real-Time Buy Signal Alerts - Newser
What recovery options are there for Lyra Therapeutics Inc.July 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser
Will Lyra Therapeutics Inc. rebound enough to break evenStop Loss & Daily Stock Trend Reports - Newser
Developing predictive dashboards with Lyra Therapeutics Inc. data2025 Price Action Summary & Expert Curated Trade Ideas - Newser
Applying sector rotation models to Lyra Therapeutics Inc.Entry Point & High Accuracy Trade Signal Alerts - Newser
News impact scoring models applied to Lyra Therapeutics Inc.2025 Volatility Report & Weekly Hot Stock Watchlists - Newser
Lyra Therapeutics shares fall 1.54% after-hours following a corporate presentation. - AInvest
Lyra Therapeutics : Corporate PresentationSeptember 2025 (ffc804) - MarketScreener
What momentum shifts mean for Lyra Therapeutics Inc.Weekly Profit Recap & Free Long-Term Investment Growth Plans - Newser
What MACD signals say about Lyra Therapeutics Inc.2025 Price Targets & AI Driven Stock Movement Reports - Newser
Can Lyra Therapeutics Inc. grow without external fundingCPI Data & AI Enhanced Trading Signals - خودرو بانک
Is Lyra Therapeutics Inc. forming a double bottom2025 Earnings Surprises & Reliable Intraday Trade Plans - خودرو بانک
Has Lyra Therapeutics Inc. formed a bullish divergenceTrade Analysis Summary & Real-Time Buy Zone Alerts - Newser
What to expect from Lyra Therapeutics Inc. in the next 30 daysJuly 2025 News Drivers & Fast Entry Momentum Alerts - Newser
Predicting Lyra Therapeutics Inc. trend using moving averagesWeekly Trend Recap & Fast Entry Momentum Alerts - Newser
Why Lyra Therapeutics Inc. is moving todayJuly 2025 Pullbacks & Reliable Breakout Forecasts - Newser
What is the dividend yield of Lyra Therapeutics Inc.2025 Retail Activity & Weekly Top Gainers Trade List - خودرو بانک
Can Lyra Therapeutics Inc. reach resistance levels soonJuly 2025 Catalysts & Accurate Entry/Exit Alerts - خودرو بانک
What momentum shifts mean for Lyra Therapeutics IncMarket Growth Summary & Risk Managed Trade Strategies - Newser
Chart based exit strategy for Lyra Therapeutics Inc.Swing Trade & Daily Price Action Insights - Newser
Institutional scanner results for Lyra Therapeutics Inc.2025 Stock Rankings & Consistent Profit Alerts - Newser
Stop Loss: Why is Lyra Therapeutics Inc. stock going downTrade Risk Summary & Growth Focused Entry Point Reports - خودرو بانک
Geopolitics Watch: What are the analyst revisions for Lyra Therapeutics Inc.Is BBAR stock a good investment in YEARJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Lyra Therapeutics Inc. stock outlook for YEAR2025 Market Trends & Verified Entry Point Signals - Newser
Why is Lyra Therapeutics Inc. stock going down2025 Sector Review & Expert-Curated Trade Recommendations - خودرو بانک
How to forecast Lyra Therapeutics Inc. trends using time seriesGap Up & Free Expert Approved Momentum Trade Ideas - Newser
Exit strategy if you’re trapped in Lyra Therapeutics Inc.2025 Analyst Calls & Reliable Trade Execution Plans - Newser
Is Lyra Therapeutics Inc. forming a breakout patternQuarterly Portfolio Report & Fast Entry Momentum Alerts - خودرو بانک
Is Lyra Therapeutics Inc. benefiting from innovation trendsRate Cut & Precise Swing Trade Alerts - خودرو بانک
Can volume confirm reversal in Lyra Therapeutics Inc.GDP Growth & Weekly Market Pulse Updates - Newser
Aug Big Picture: Can Lyra Therapeutics Inc. lead its sector in growth2025 Price Momentum & Free Expert Verified Stock Movement Alerts - خودرو بانک
Is Lyra Therapeutics Inc. showing signs of accumulation2025 Technical Overview & Expert Verified Stock Movement Alerts - Newser
What are Lyra Therapeutics Inc.’s recent SEC filings showingLong Setup & Step-by-Step Swing Trade Plans - خودرو بانک
Intraday Charts Show Spike in Lyra Therapeutics Inc. Activity getLinesFromResByArray error: size == 0 - 강소기업뉴스
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78) - MSN
Lyra Therapeutics Inc Stock (LYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):